Drugmaker Gilead Owes Rival $200 Million In Patent LawsuitThe federal jury in a patent trial has ordered Bay Area-based drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents for hepatitis C drugs.
Drugmaker Gilead Halts Studies On Cancer Drug Zydelig Due To Side Effects, DeathDrugmaker Gilead Sciences Inc. has halted several patient studies of its cancer drug, Zydelig, because of increased risk of death and serious side effects.
Massachusetts Investigates $1,000 Cost Of Gilead Hepatitis C PillThe Massachusetts attorney general's office said Wednesday that it is investigating whether the Bay Area makers of a breakthrough treatment for hepatitis C are violating state law by pricing the drugs too high.
Gilead To Give Away Pricey Hepatitis C Drug Sovaldi In Republic Of GeorgiaGilead wants other countries and agencies to back a plan to eradicate hepatitis C by giving away its blockbuster treatment to poor countries.
Gilead Sciences Doubles Its Profit To $12.1 Billion On Strength Of $1,000 Per Pill Hepatitis DrugA Bay Area pharmaceutical firm is among other top drug makers facing scrutiny over enormous profits, the price charged for drugs, and how much the company spends on marketing versus research and development.
Oregon, Illinois Medicaid Programs Place Tight Restrictions On Gilead $1,000-Per-Pill Hepatitis C Drug SovaldiAn Oregon Medicaid committee is expected Thursday to significantly scale back access to an effective—but expensive—new drug used to treat hepatitis C, the second state to retrict access to the drug in two days.
Gilead Profit Soars Into The Billions, Fueled By Hepatitis C Drug That Costs $1,000 Per PillThe maker of a hepatitis C drug that costs about $1,000 per pill on Wednesday delivered a quarterly earnings report that shattered expectations, showing the company tripled its profit which is now in the billions.
Foster City-Based Gilead's Breakthrough Hepatitis Drug Costs $1,000 Per Pill Doctors are calling a newly-approved drug a “ revolution” in treating the most common blood-borne infection in the United States. But patient advocates warn how those who need it may not be able to afford it; and noisy protests from Paris to San Francisco are trying to drive the displeasure over the price into the open.
FDA Rejects 2 HIV Drugs From Gilead SciencesGilead Sciences said Monday that the Food and Drug Administration rejected two marketing applications for HIV treatments, citing quality control problems at the Foster Citry company's manufacturing facilities.
FDA Panel Backs Foster City Drug Maker’s HIV Prevention Pill The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.
UC Scientists Testing HIV Prevention PillThe UC-based California HIV/AIDS Research Program (CHRP) has awarded grants totaling $11.8 million to see if a current HIV drug can be used to prevent the onset of the virus.
California Officials Seek Lower Prices For AIDS DrugsCalifornia's treasurer on Friday became the second state official to ask leading makers of AIDS medications to extend lower prices and rebates for drugs to help the state's budget crisis.